Presentations GENFIT - Corporate presentation - AASLD - ACLF Day - November 2023 GENFIT - Corporate presentation - Investor Events - September 2023 GENFIT - Corporate presentation - Positive Results from Phase III ELATIVE® Trial - June 2023 GENFIT 2022 Extra-Financial Performance Report Video Replay - Interview of Pascal Prigent, CEO & Dean Hum, CSO at SVB Securities Global Biopharma Conference - February 15th, 2023 GENFIT - Corporate Presentation for Corporate Access and Biotech Showcase during JP Morgan Healthcare Conference - January 2023 Video Replay - GENFIT Pipeline Days – October 5th & 19th, 2022 – Paris, NYC GENFIT - NYC Pipeline Day Presentation - October 2022 GENFIT - Paris Pipeline Day Presentation - October 2022 GENFIT 2021 Extra-Financial Performance Report GENFIT Corporate Presentation - April 2022 2021 GENFIT Half Year Business and Financial Report 2020 Registration Document (French version) GENFIT PBC Day Review - Februrary 2021 GENFIT Shareholders’ Extraordinary General Meeting – January 25, 2021 - Presentation with Verbatim (French only) GENFIT Shareholders’ Extraordinary General Meeting – January 13, 2021 (French only) - Replay GENFIT Shareholders’ Extraordinary General Meeting – January 13, 2021 - Presentation with Verbatim (French only) GENFIT Extra-financial Performance - 2020 Statement
Video Replay - Interview of Pascal Prigent, CEO & Dean Hum, CSO at SVB Securities Global Biopharma Conference - February 15th, 2023
GENFIT - Corporate Presentation for Corporate Access and Biotech Showcase during JP Morgan Healthcare Conference - January 2023
GENFIT Shareholders’ Extraordinary General Meeting – January 25, 2021 - Presentation with Verbatim (French only)
GENFIT Shareholders’ Extraordinary General Meeting – January 13, 2021 - Presentation with Verbatim (French only)
